May 13 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.73 1.98 3.33
(+38.0 pct) (-6.1 pct) (+21.8 pct)
Operating 298 mln 68 mln 319 mln
(+337.7 pct) (-70.6 pct) (+7.0 pct)
Recurring 248 mln 47 mln 288 mln
(+425.0 pct) (-74.8 pct) (+16.1 pct)
Net
Net 142 mln 12 mln 204 mln
(-88.4 pct) (+43.3 pct)
EPS 30.09 yen 2.93 yen 43.10 yen
EPS Diluted 28.65 yen 2.74 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Enbio Holdings, Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T
((Tokyo Headline News Desk +813 6441 1812))